# Preparation of Crystalline Cefquinome Free Acid via Reverse Anti-Solvent Crystallization: Physicochemical Characterization and Pharmacokinetics in Chickens

**Authors:** Liping Xu, Qiaoyi Zhou, Liangzhu Chen, Feike Zhao, Binghu Fang

PMC · DOI: 10.3390/pharmaceutics18030333 · Pharmaceutics · 2026-03-07

## TL;DR

This paper describes a new method to improve the solubility and effectiveness of a drug called cefquinome in chickens.

## Contribution

A novel crystalline form of cefquinome free acid was prepared and shown to have better solubility and bioavailability.

## Key findings

- The new crystalline cefquinome free acid (CFQ) has higher water solubility and faster dissolution than the sulfate form.
- In chickens, CFQ showed a longer half-life and increased drug availability compared to the sulfate form.
- The relative bioavailability of CFQ reached 139.92% compared to the commercial sulfate form.

## Abstract

Background: The therapeutic efficiency of cefquinome is currently limited by the low solubility and short half-life of its commercial sulfate form (SCFQ). This study aimed to improve these properties by preparing a novel crystalline cefquinome free acid (CFQ) via a reverse anti-solvent crystallization method. Methods: The optimal crystallization conditions were determined through a single factor test. And the product was characterized using X-ray powder diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy. Meanwhile, in vitro and in vivo pharmaceutical evaluation were conducted. Results: CFQ was sucessfully obtained and the optimal crystallization conditions were determined. Comparative in vitro studies showed that CFQ exhibited improved water solubility and dissolution rates compared to SCFQ. In vivo pharmacokinetic evaluations in chickens demonstrated that CFQ significantly prolonged the elimination half-life and increased the area under the concentration-time curve, achieving a relative bioavailability of 139.92%. Conclusions: The novel CFQ crystal effectively overcomes the crystallization difficulties of cefquinome and offers a promising alternative formulation with enhanced bioavailability and sustained drug action.

## Linked entities

- **Chemicals:** cefquinome (PubChem CID 5464355), cefquinome sulfate (PubChem CID 9577261)
- **Species:** Gallus gallus (taxon 9031)

## Full-text entities

- **Chemicals:** CFQ (-), sulfate (MESH:D013431), water (MESH:D014867), cefquinome (MESH:C068212)
- **Species:** Gallus gallus (bantam, species) [taxon 9031]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029427/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029427/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029427/full.md

---
Source: https://tomesphere.com/paper/PMC13029427